Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Avecho Biotechnology Limited ( (AU:AVE) ).
Avecho Biotechnology Limited has requested a trading halt on its securities pending an announcement concerning an exclusive license and development agreement. This move is intended to manage the company’s continuous disclosure obligations and is expected to impact its market operations once the announcement is made.
More about Avecho Biotechnology Limited
Avecho Biotechnology Limited operates in the biotechnology industry, focusing on the development of innovative drug delivery systems. The company is known for its proprietary technology that enhances the delivery and efficacy of pharmaceutical products.
Current Market Cap: A$20.6M
For detailed information about AVE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue